Alterations in interferon-gamma and nitric oxide levels in human echinococcosis

被引:18
作者
Ait, Aissa S. [1 ]
Amri, M. [1 ]
Bouteldja, R. [1 ]
Wietzerbin, J. [1 ]
Touil-Boukoffa, C. [1 ]
机构
[1] Inst Curie, INSERM, U365, Sect Rech, Paris, France
关键词
nitric oxide; nitric oxide synthase-2; interferon gamma; Echinococcus granulosus;
D O I
10.1170/T699
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human cystic hydatid disease is characterized by the long-term coexistence of Echinococcus granulosus and its host without effective rejection of the parasite. This parasitic helminth infection currently constitutes a major health problem in Algeria. We investigated interferon-gamma (IFN-gamma) and nitrite (NO2-) production in PMBC culture supernatants from Algerian patients (n=35), stimulated by a major antigen (antigen 5). Nitrite was also observed in 74 sera and 28 cyst fluids of patients carrying cysts in different locations. In addition, we report the detection of Nitric Oxide Synthase-2 (NOS2) in liver biopsies of patients (n=8) by an immunochemical method using human NOS2 antibody. In vivo nitrite levels in host sera and cyst biological fluid point to a tight relation between host response and macro-parasite effects. Our in vitro results indicate a correlation between nitrite and INF-gamma production in PBMC culture supernatants. Furthermore, by immunohistochemistry NOS2 expression was observed in hepatocytes and Kupffer cells from hydatid patients. Collectively, our data imply NO production in host defense against the extracellular parasite, probably in response to an IFN-gamma activating signal. Concomitant enhanced levels of IFN-gamma and nitrite represent useful indicators of the clinical aggressiveness of hydatidosis.
引用
收藏
页码:65 / 70
页数:6
相关论文
共 29 条
[1]   Treatment of hydatid disease [J].
Anadol D. ;
Özçelik U. ;
Kiper N. ;
Göçmen A. .
Paediatric Drugs, 2001, 3 (2) :123-135
[2]  
Anstey Nicholas M, 2002, Methods Mol Med, V72, P461, DOI 10.1385/1-59259-271-6:461
[3]   The anti-parasitic effects of nitric oxide [J].
Ascenzi, P ;
Bocedi, A ;
Gradoni, L .
IUBMB LIFE, 2003, 55 (10-11) :573-578
[4]   Nitric oxide in parasitic infections [J].
Brunet, LR .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (08) :1457-1467
[5]   IFN-γ and IL-4 differently regulate inducible NO synthase gene expression through IRF-1 modulation [J].
Coccia, EM ;
Stellacci, E ;
Marziali, G ;
Weiss, G ;
Battistini, A .
INTERNATIONAL IMMUNOLOGY, 2000, 12 (07) :977-985
[6]  
Colasanti M, 2002, INT J MOL MED, V9, P131
[7]  
Drapier JC, 1997, PATHOL BIOL, V45, P110
[8]   NITRIC-OXIDE PRODUCTION BY HUMAN MONOCYTES - EVIDENCE FOR A ROLE OF CD23 [J].
DUGAS, B ;
MOSSALAYI, MD ;
DAMAIS, C ;
KOLB, JP .
IMMUNOLOGY TODAY, 1995, 16 (12) :574-580
[9]   Increased nitric oxide production in patients with Behcet's disease: Is it a new activity marker? [J].
Evereklioglu, C ;
Turkoz, Y ;
Er, H ;
Inaloz, HS ;
Ozbek, E ;
Cekmen, M .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (01) :50-54
[10]   Cellular and humoral immune responses of hydatidosis patients to Echinococcus granulosus purified antigens [J].
Kharebov, A ;
Nahmias, J ;
ElOn, J .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1997, 57 (05) :619-625